Inventiva Stock (NASDAQ: IVA) stock price, news, charts, stock research, profile.
Open | $3.250 |
Close | $3.220 |
Volume / Avg. | 9.058K / 40.367K |
Day Range | 3.165 - 3.260 |
52 Wk Range | 2.220 - 5.050 |
Market Cap | $176.151M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 0.16% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Inventiva (NASDAQ: IVA) through any online brokerage.
Other companies in Inventiva’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Outlook Therapeutics (NASDAQ:OTLK), bluebird bio (NASDAQ:BLUE), Atossa Therapeutics (NASDAQ:ATOS) and GlycoMimetics (NASDAQ:GLYC).
The latest price target for Inventiva (NASDAQ: IVA) was reported by Canaccord Genuity on Monday, April 8, 2024. The analyst firm set a price target for 20.00 expecting IVA to rise to within 12 months (a possible 491.72% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Inventiva (NASDAQ: IVA) is $3.38 last updated April 16, 2024 at 8:51 AM EDT.
There are no upcoming dividends for Inventiva.
Inventiva’s FY earnings are confirmed for Tuesday, April 30, 2024.
There is no upcoming split for Inventiva.
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.